In the aortic tissue of patients with familial ATAA, Marfan syndrome, or patients who have mutations in TGFB2, TGFB3, TGFBR or SMAD3, increased TGFB signaling was reported [28]. The gene discussed is SMAD3; the disease is Marfan syndrome.